Oil-Dri of America (ODC) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
1 Feb, 2026Executive summary
Achieved record net income of $30.9M for the first nine months, up 76% year-over-year, surpassing any previous full fiscal year, with EPS of $4.59 (Common) and $3.45 (Class B).
Net sales grew 6% year-over-year to $323.9M for the nine months ended April 30, 2024, driven by higher prices and favorable product mix.
Completed the $46M acquisition of Ultra Pet, a leading silica gel-based crystal cat litter supplier, to accelerate entry into the fast-growing crystal litter segment; expected to be immediately accretive.
Focus remains on value creation from sorbent minerals, with legacy business and higher-value product sales driving results.
Operating cash flow increased to $36.9M, supporting capital expenditures and strategic acquisition.
Financial highlights
Fiscal Q3 consolidated net sales reached $106.8M, up 1% year-over-year, marking the 12th consecutive quarter of sales growth.
Gross profit for Q3 was $30.1M, a 10% increase over the prior year; gross margin expanded to 28% from 26%.
SG&A expenses rose to $19.7M in Q3 and $53.3M for nine months, driven by higher compensation, advertising, and acquisition costs.
Cash and equivalents increased to $46.8M from $29.7M year-over-year.
Year-to-date capital expenditures totaled $24M, up from $17M, supporting facility upgrades and growth.
Outlook and guidance
Confident in finishing the year ahead of last year, with strong growth expected in renewable diesel and animal health.
Ultra Pet acquisition expected to be accretive from day one, with integration and advertising costs expected to remain elevated in Q4 FY2024.
Continued focus on growth opportunities, innovation, and expanding both branded and private label offerings.
Management expects cash flow and available liquidity to be sufficient for ongoing operations and investments.
Latest events from Oil-Dri of America
- Q2 net sales hit $117.7M, EBITDA $22M, with resilience despite weather disruptions.ODC
Q2 202612 Mar 2026 - Record sales, margin expansion, and Ultra Pet integration drive strong growth outlook.ODC
Q4 202419 Jan 2026 - Record sales, profit, and margin expansion driven by Ultra Pet and high-value segment growth.ODC
Q1 202511 Jan 2026 - Record FY2025 results with double-digit growth, strong cash flow, and a positive FY2026 outlook.ODC
Q4 20257 Jan 2026 - Record sales, margin expansion, and robust B2B and animal health growth in Q2.ODC
Q2 202526 Dec 2025 - Record results in 2025 and strong Q1 FY2026 earnings drive continued growth and investment.ODC
Q1 2026 & AGM 20259 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve stock split amid strong governance focus.ODC
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and a 2:1 stock split approval.ODC
Proxy Filing1 Dec 2025 - Virtual meeting to elect nine directors, ratify auditor, and highlight ESG and governance priorities.ODC
Proxy Filing1 Dec 2025